IBI310 in Combination with Sintilimab in Patients with DNA Mismatch Repair Deficient (dMMR)/microsatellite Instability High (MSI-H) Locally-advanced or Metastatic Colorectal Cancer
Clinical trial NCT04258111 · TERMINATED
Trial details
- NCT number
- NCT04258111
- Sponsor
- Innovent Biologics (Suzhou) Co. Ltd.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-27
- Primary completion
- 2020-10-26
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.